Literature DB >> 28027343

Recommendations for the Treatment of Patients With Parkinson Disease During Ramadan.

Philippe Damier1, Jasem Al-Hashel2.   

Abstract

IMPORTANCE: Every year, Ramadan fasting is practiced by many Muslim individuals. In cases of chronic disease, religious texts allow fasting to be broken. However, many believers still want to fast even at the risk of damaging their health. To our knowledge, there are no published recommendations on the medical management of Parkinson disease (PD) during Ramadan. Effective treatments exist in PD and usually require several daily drug intakes. Apart from worsening symptoms, interrupting PD treatment might lead to a severe withdrawal syndrome. OBSERVATIONS: Although no specific studies on this topic have led to formal recommendations, we suggest some options for adapting the treatment for patients who fast during Ramadan. The general principle is based on switching the patient's treatment to an equivalent dosage of a dopamine agonist that can be administered once daily or by transdermal patch. However, such an option is only feasible for patients who require a moderate amount of PD treatment and can tolerate dopamine agonist therapy. CONCLUSIONS AND RELEVANCE: Because many patients with PD require regular multiple daily administration of dopamine-replacement medication, the management of Ramadan fasting is not easy. Switching the patient's treatment to an equivalent dosage of a dopamine agonist that can be administered once daily or by transdermal patch seems to be a reasonable option to consider for patients treated with a low-to-moderate amount of PD medication.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28027343     DOI: 10.1001/jamaneurol.2016.4291

Source DB:  PubMed          Journal:  JAMA Neurol        ISSN: 2168-6149            Impact factor:   18.302


  2 in total

1.  Managing medications during Ramadan fasting.

Authors:  Kelly Grindrod; Wasem Alsabbagh
Journal:  Can Pharm J (Ott)       Date:  2017-04-03

2.  Patient-guided modifications of oral anticoagulant drug intake during Ramadan fasting: a multicenter cross-sectional study.

Authors:  AbdulAziz Batarfi; Haitham Alenezi; Abdulrahman Alshehri; Saud Balelah; Hameedullah Kazim; Mohammed Algthami; Mariam M Hussain; Nada Alshehri; Rahaf Alsharif; Hadeel Ashour; Mutaz Althobaiti; Shomokh Alotaibi; Helmuth Steinmetz; Christian Foerch
Journal:  J Thromb Thrombolysis       Date:  2021-02       Impact factor: 2.300

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.